Erika Rumble
Women's Health · Oklahoma City, OKNPI 1437695715
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,069 of the $2,315 with a category attached, or 89.4%. It is spread thinly across 23 manufacturers, the largest accounting for just 21.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,605, more than ten times the $118 reported in 2022.
Across 80 payments — averaging $28.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Daiichi Sankyo Inc.$499
- Gilead$262
- Lilly USA, LLC$209
- Merck$147
- Mayne Pharma Commercial LLC$146
- Genentech, Inc.$131
- plus $921 from 17 others
What the payments were for
- Food & beverage$2,06989%
- Education$24611%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Daiichi Sankyo Inc. | 11 | $499 |
| Gilead | 3 | $262 |
| Lilly USA, LLC | 6 | $209 |
| Merck | 7 | $147 |
| Mayne Pharma Commercial LLC | 2 | $146 |
| Genentech, Inc. | 1 | $131 |
| AbbVie | 7 | $121 |
| Stemline Therapeutics Inc. | 6 | $114 |
| Eisai Inc. | 4 | $102 |
| AstraZeneca | 5 | $100 |
| Novartis | 5 | $97 |
| Therapeuticsmd, Inc. | 4 | $66 |
| Genentech USA, Inc. | 3 | $65 |
| Organon | 4 | $59 |
| Astellas Pharma US Inc | 3 | $43 |
| Elucent Medical | 2 | $32 |
| Tersera Therapeutics LLC | 1 | $23 |
| Myovant Sciences Inc. | 1 | $19 |
| Caris MPI, Inc. | 1 | $18 |
| Puma Biotechnology, Inc. | 1 | $18 |
| Viiv Healthcare Company | 1 | $16 |
| Myriad Genetic Laboratories, Inc. | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Enhertu$139
- Itovebi$131
- Trodelvy$125
- NEXTSTELLIS$125
- DATROWAY$124
How this compares
$2,315 in reported general payments places this provider in the 80th percentile of 62 women's health providers in Oklahoma.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 12 | $9,920 |
| Estradiol | 24 | $1,645 |
Paid to pharmacies, not to this prescriber.
Other women's health in Oklahoma City
- Hilary MillerOklahoma City$38K
- Beverly CotnerOklahoma City$4K
- Whitney HunterOklahoma City$3K
- Bethany CookOklahoma City$3K
- Jaclyn ShaverOklahoma City$2K
- Meredith DewitteOklahoma City$2K
- Charnelle DeanOklahoma City$711
- Joyce TowOklahoma City$507
- Maria MeyerOklahoma City$378
- Amanda KenneyOklahoma City$343
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.